Cargando…
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data
BACKGROUND: Novel blood-based protein biomarkers may be of value for efficient, accurate, and non-invasive diagnosis of pancreatic cancer. This study assesses the diagnostic accuracy of newly recognized blood-based protein biomarkers for detecting pancreatic cancer, and investigates their added valu...
Autores principales: | Boyd, Lenka N.C., Ali, Mahsoem, Leeflang, Mariska M.G., Treglia, Giorgio, de Vries, Ralph, Le Large, Tessa Y.S., Besselink, Marc G., Giovannetti, Elisa, van Laarhoven, Hanneke W.M., Kazemier, Geert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706531/ https://www.ncbi.nlm.nih.gov/pubmed/36457649 http://dx.doi.org/10.1016/j.eclinm.2022.101747 |
Ejemplares similares
-
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers
por: Boyd, Lenka N. C., et al.
Publicado: (2023) -
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
por: Boyd, Lenka N. C., et al.
Publicado: (2022) -
Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
por: Le Large, Tessa Y.S., et al.
Publicado: (2020) -
Multidrug‐resistant transporter expression does not always result in drug resistance
por: Le Large, Tessa Ya Sung, et al.
Publicado: (2018) -
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
por: Boyd, Lenka N. C., et al.
Publicado: (2023)